The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
MicroRNA profiling in human medulloblastoma
Abstract
Medulloblastoma is an aggressive brain malignancy with high incidence in childhood. Current treatment approaches have limited efficacy and severe side effects. Therefore, new risk‐adapted therapeutic strategies based on molecular classification are required. MicroRNA expression analysis has emerged as a powerful tool to identify candidate molecules playing an important role in a large number of malignancies. However, no data are yet available on human primary medulloblastomas. A high throughput microRNA expression profiles was performed in human primary medulloblastoma specimens to investigate microRNA involvement in medulloblastoma carcinogenesis. We identified specific microRNA expression patterns which distinguish medulloblastoma differing in histotypes (anaplastic, classic and desmoplastic), in molecular features (ErbB2 or c‐Myc overexpressing tumors) and in disease‐risk stratification. MicroRNAs expression profile clearly differentiates medulloblastoma from either adult or fetal normal cerebellar tissues. Only a few microRNAs displayed upregulated expression, while most of them were downregulated in tumor samples, suggesting a tumor growth‐inhibitory function. This property has been addressed for miR‐9 and miR‐125a, whose rescued expression promoted medulloblastoma cell growth arrest and apoptosis while targeting the proproliferative truncated TrkC isoform. In conclusion, misregulated microRNA expression profiles characterize human medulloblastomas, and may provide potential targets for novel therapeutic strategies. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,581
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., & Jacks, T. (2007) · Nature Genetics · doi:10.1038/ng2003 · Cited by 1,463
MicroRNA Signatures in Human Ovarian Cancer
Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.-G., Alder, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1936 · Cited by 1,394
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
Calin, G. A., Liu, C.-G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404432101 · Cited by 1,285
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
Schoenherr, C. J., & Anderson, D. J. (1995) · Science · doi:10.1126/science.7871435 · Cited by 976
Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Kosik, K. S. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2037 · Cited by 826
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 812
Reciprocal actions of REST and a microRNA promote neuronal identity
Conaco, C., Otto, S., Han, J.-J., & Mandel, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511041103 · Cited by 736
Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., Chen, C., Ambros, V. R., & Israel, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2698 · Cited by 727
Regulation of miRNA expression during neural cell specification
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03978.x · Cited by 707
The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development
Visvanathan, J., Lee, S., Lee, B., Lee, J. W., & Lee, S.-K. (2007) · Genes & Development · doi:10.1101/gad.1519107 · Cited by 683
Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Thompson, M. C., Fuller, C., Hogg, T. L., Dalton, J., Finkelstein, D., Lau, C. C., Chintagumpala, M., Adesina, A., Ashley, D. M., Kellie, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4974 · Cited by 668
MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., Packer, R. J., Cogen, P., & Stephan, D. A. (2001) · Nature Genetics · doi:10.1038/ng731 · Cited by 455
Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406
Hammond, S. M. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.005 · Cited by 406
Garzon, R., Pichiorri, F., Palumbo, T., Visentini, M., Aqeilan, R., Cimmino, A., Wang, H., Sun, H., Volinia, S., Alder, H., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210186 · Cited by 362
Medulloblastoma: signalling a change in treatment
Gilbertson, R. J. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01424-x · Cited by 298
Gajjar, A., Hernan, R., Kocak, M., Fuller, C., Lee, Y., McKinnon, P. J., Wallace, D., Lau, C., Chintagumpala, M., Ashley, D. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.032 · Cited by 279
Development and developmental disorders of the human cerebellum
ten Donkelaar, H. J., Lammens, M., Wesseling, P., Thijssen, H. O., & Renier, W. O. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0199-9 · Cited by 268
Wu, J., & Xie, X. (2006) · Genome Biology · doi:10.1186/gb-2006-7-9-r85 · Cited by 260
Oncogenic Potential of the miR-106-363 Cluster and Its Implication in Human T-Cell Leukemia
Landais, S., Landry, S., Legault, P., & Rassart, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4478 · Cited by 241
TrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors
Grotzer, M. A., Janss, A. J., Fung, K.-M., Biegel, J. A., Sutton, L. N., Rorke, L. B., Zhao, H., Cnaan, A., Phillips, P. C., Lee, V. M.-Y., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1027 · Cited by 223
Classifying the medulloblastoma: insights from morphology and molecular genetics
Ellison, D. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00419.x · Cited by 218
The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells
Lawinger, P., Venugopal, R., Guo, Z.-S., Immaneni, A., Sengupta, D., Lu, W., Rastelli, L., Marin Dias Carneiro, A., Levin, V., Fuller, G. N., et al. (2000) · Nature Medicine · doi:10.1038/77565 · Cited by 187
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
Gilbertson, R. J., Perry, R., Kelly, P. J., Pearson, A. D. J., & Lunec, J. (1997) · PubMed · doi:10.25405/ncl.34590669 · Cited by 185
van der Laan, M. J., Dudoit, S., & Pollard, K. S. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1042 · Cited by 176
Grotzer, M. A., Hogarty, M. D., Janss, A. J., Liu, X., Zhao, H., Eggert, A., Sutton, L. N., RORKE, L. B., Brodeur, G. M., & Phillips∥, P. C. (2001) · PubMed · Cited by 168
Laneve, P., Di Marcotullio, L., Gioia, U., Fiori, M. E., Ferretti, E., Gulino, A., Bozzoni, I., & Caffarelli, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700071104 · Cited by 165
Self-citationC-MYC expression in medulloblastoma and its prognostic value
Herms, J., Neidt, I., Lüscher, B., Sommer, A., Schürmann, P., Schröder, T., Bergmann, M., Wilken, B., Probst-Cousin, S., Hernáiz-Driever, P., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000920)89:5<395::aid-ijc1>3.0.co;2-v · Cited by 164
Su, X., Gopalakrishnan, V., Stearns, D. S., Aldape, K., Lang, F. F., Fuller, G. N., Snyder, E., Eberhart, C. G., & Majumder, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1666-1678.2006 · Cited by 149
Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas.
Kim, J. Y. H., Sutton, M. E., Lu, D. J., Cho, T. A., Goumnerova, L., Goritchenko, L., Kaufman, J. R., Lam, K., Billett, A. L., Tarbell, N. J., et al. (1999) · PubMed · Cited by 137
Fuller, G. N., Su, X., Price, R. E., Cohen, Z. R., Lang, F. F., Sawaya, R. A., & Majumder, S. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0228 · Cited by 108
Hohjoh, H., & Fukushima, T. (2006) · Gene · doi:10.1016/j.gene.2006.11.018 · Cited by 83
Hedgehog checkpoints in medulloblastoma: the chromosome 17p deletion paradigm
Ferretti, E., Smaele, E. D., Marcotullio, L. D., Screpanti, I., & Gulino, A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.10.005 · Cited by 73
Self-citationFerretti, E., Marcotullio, L. D., Gessi, M., Mattei, T., Greco, A., Pò, A., Smaele, E. D., Giangaspero, F., Riccardi, R., Rocco, C. D., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209716 · Cited by 45
Self-citationMutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastoma
Gilbertson, R. J., Langdon, J. A., Hollander, A. B., Hernán, R., Hogg, T. L., Gajjar, A. J., Fuller, C. E., & Clifford, S. C. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.023 · Cited by 44
Marcotullio, L. D., Ferretti, E., Smaele, E. D., Screpanti, I., & Gulino, A. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:193 · Cited by 25
Self-citation
Cited by
Farazi, T. A., Spitzer, J. I., Morozov, P., & Tuschl, T. (2011) · The Journal of Pathology · doi:10.1002/path.2806 · Cited by 895
Cho, Y.-J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Berhoukim, R., Amani, V., Goumnerova, L., Eberhart, C. G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5148 · Cited by 717
Farazi, T. A., Hoell, J. I., Morozov, P., & Tuschl, T. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-5590-1_1 · Cited by 693
Dicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., & Barres, B. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.027 · Cited by 577
MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
Cho, W. C. S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.014 · Cited by 486
Metadata
- Authors
- Ferretti, E., De Smaele, E., Po, A., Di Marcotullio, L., Tosi, E., Espinola, M. S. B., Di Rocco, C., Riccardi, R., Giangaspero, F., Farcomeni, A., Nofroni, I., Laneve, P., Gioia, U., Caffarelli, E., Bozzoni, I., Screpanti, I., & Gulino, A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-10-30
- Volume
- 124
- Issue
- 3
- Pages
- 568-577
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1977376661
- Cited by
- 292
- References
- 48
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.